Gewirtz DA - Search Results

1

Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.

Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA. Grant S, et al. Among authors: gewirtz da. Cancer Res. 1992 Nov 15;52(22):6270-8. Cancer Res. 1992. PMID: 1423273

2

Effect of pharmacologically relevant concentrations of mitoxantrone on the in vitro growth of leukemic blast progenitors.

Grant S, Arlin Z, Gewirtz D, Feldman E. Grant S, et al. Leukemia. 1991 Apr;5(4):336-9. Leukemia. 1991. PMID: 2027301

3

Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.

Gewirtz DA, Ellis AL, Randolph JK, Yanovich S, Swerdlow PS, Povirk LF, Yalowich JC. Gewirtz DA, et al. Cancer Commun. 1989;1(3):175-80. Cancer Commun. 1989. PMID: 2561738

4

Characterization of a K562 multidrug-resistant cell line.

Yanovich S, Hall RE, Gewirtz DA. Yanovich S, et al. Among authors: gewirtz da. Cancer Res. 1989 Aug 15;49(16):4499-503. Cancer Res. 1989. PMID: 2568171

5

Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.

Woods KE, Ellis AL, Randolph JK, Gewirtz DA. Woods KE, et al. Among authors: gewirtz da. Cancer Res. 1989 Sep 1;49(17):4846-51. Cancer Res. 1989. PMID: 2758416

6

Evidence for inhibition of growth related to compromised DNA synthesis in the interaction of daunorubicin with H-35 rat hepatoma.

Munger C, Ellis A, Woods K, Randolph J, Yanovich S, Gewirtz D. Munger C, et al. Cancer Res. 1988 May 1;48(9):2404-11. Cancer Res. 1988. PMID: 3356005

7

Variable effects of tamoxifen on human hematopoietic progenitor cell growth and sensitivity to doxorubicin.

Woods KE, Grant S, Yanovich S, Gewirtz DA. Woods KE, et al. Among authors: gewirtz da. Cancer Chemother Pharmacol. 1994;33(6):509-14. doi: 10.1007/BF00686510. Cancer Chemother Pharmacol. 1994. PMID: 7511065

8

Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin.

Fornari FA Jr, Jarvis WD, Grant S, Orr MS, Randolph JK, White FK, Mumaw VR, Lovings ET, Freeman RH, Gewirtz DA. Fornari FA Jr, et al. Among authors: gewirtz da. Cell Growth Differ. 1994 Jul;5(7):723-33. Cell Growth Differ. 1994. PMID: 7947387

9

Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells.

Jarvis WD, Fornari FA Jr, Browning JL, Gewirtz DA, Kolesnick RN, Grant S. Jarvis WD, et al. Among authors: gewirtz da. J Biol Chem. 1994 Dec 16;269(50):31685-92. J Biol Chem. 1994. PMID: 7989341 Free article.

10

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.

Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S. Jarvis WD, et al. Among authors: gewirtz da. Biochem Pharmacol. 1994 Mar 2;47(5):839-52. doi: 10.1016/0006-2952(94)90484-7. Biochem Pharmacol. 1994. PMID: 8135859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters